INTRODUCTION
Malonyl-CoA is a key intermediate of fatty acid synthesis in lipogenic organs. It is also an inhibitor of carnitine-palmitoyltransferase I, a regulator of fatty acid oxidation in most tissues (1) (2) (3) . A number of studies have documented the modulation by malonyl-CoA of fatty acid oxidation in the heart under physiological and pathological conditions, such as maturation (4) diabetes (5), increased cardiac work (6) , and postischemic reperfusion (7) . In the heart, malonylCoA formed by cytosolic acetyl-CoA carboxylase (ACC) is, as far as is known, disposed only via decarboxylation catalyzed by malonyl-CoA decarboxylase (MCD). Thus, cytosolic acetylCoA and malonyl-CoA are the two components of a substrate cycle which regulates carnitine palmitoyltransferase-I activity and the rate of mitochondrial fatty acid oxidation in the heart.
No information is available on the relationship between the concentration of malonyl-CoA and its turnover, i.e., with the flux of ACC in the intact heart. The rate of turnover of malonyl-CoA is likely to be regulated by the cytosolic acetyl-CoA concentration and by the activities of ACC and MCD. The concentrations of cytosolic acetyl-CoA and malonyl-CoA in the heart are much lower than the Km of the two enzymes for their respective substrates (6;8) . Thus, it is unlikely that the modulation of ACC and MCD activities exerts a tight control on malonyl-CoA turnover.
It was previously shown that the myocardial content of malonyl-CoA is elevated when acetylCoA levels are increased by either activation of pyruvate dehydrogenase (8;9) or by perfusing the heart with octanoate instead of palmitate or oleate (10;11) . The increase in malonyl-CoA content was independent of ACC activity. It is not clear whether the higher concentration of malonyl-CoA in the presence of octanoate reflected (i) an increase in acetyl-CoA carboxylation 5 fueled by an increase in cytosolic acetyl-CoA concentration, or/and (ii) a decrease in the flux of malonyl-CoA decarboxylation.
The goal of the present investigation was to test the hypothesis that myocardial malonyl-CoA concentration is proportional to the rate of acetyl-CoA carboxylation under physiological conditions. We recently developed a mass spectrometric technique for measuring the malonylCoA turnover in isolated organs, based on the time course of its labeling from NaH 13 CO 3 (12) .
The malonyl-CoA concentration can also be assayed in the same samples by isotope dilution using an internal standard of [U-
13
C 3 ]malonyl-CoA. We used these techniques to study the relationship between malonyl-CoA concentration in rat hearts under physiological conditions, and during pharmacological inhibition of MCD. In addition, we measured the malonyl-CoA concentration and turnover in the hearts of anesthetized pigs. other compounds (inhibitors of MCD, DMSO) were added to the perfusate as indicated in Table I .
In vivo pig experiments
Six anesthetized pigs were thoracotomized and fitted with a pump-controlled bypass between the femoral artery and the left anterior descending coronary artery (13). NaH 13 CO 3 was infused into the bypass at a rate calculated to achieve a 15% enrichment of bicarbonate/CO 2 in the infused myocardial territory. The enrichment of bicarbonate/CO 2 was measured (12) in samples of venous blood from the infused territory just before taking punch biopsies of the myocardium at 1, 10 and 60 min (two pigs at each time point)
Analytical Procedures
The concentration and 13 C-labeling of malonyl-CoA were assayed as described previously (12) .
We developed a gas chromatography-mass spectrometric assay for acetyl-CoA carboxylase activity because, in our hands, the assay with NaH 14 CO 3 had high blanks. Also, this assay measures non-acid-volatile radioactivity as the product and does not specifically identify malonyl-CoA. Our assay involves (i) incubating the tissue extract with acetyl-CoA and After centrifugation, the acid extract was brought to pH 12 with 2 M KOH and incubated at 40E for 1 hr to hydrolyze the CoA esters. After centrifuging KClO 4 , the supernatant was brought to pH 1 with 1 M HCl and evaporated in a Savant vacuum centrifuge. The residue was treated to prepare di-tertbutyldimethylsilyl malonate which was assayed by gas chromatography-mass spectrometry (12) . The amount of M1 malonyl-CoA formed was calculated from the M1/M3 mass isotopomer 1 ratio of malonate, and the ACC activity expressed in nmolCmin
. The activity of MCD in heart tissue was assayed by the method of Kerner and Hoppel (14) . Since rapid changes in the Km of MCD have been reported in rat heart (6), we measured MCD activity at a low substrate concentration (0.01 mM malonyl-CoA; ~5 to 10% of maximal activity) and under near Vmax conditions (0.3 mM malonyl-CoA).
Calculations and statistics
For each group of perfusions with NaH ).
To test whether the MCD inhibitors significantly affected the kinetic constant of the malonyl-CoA pool, we performed a log rank test (15) (Chi-square distribution with one degree of freedom), assuming that the labeling of malonyl-CoA is described by the above exponential. Adjustment for multiple comparisons was done by Holm's procedure (16) .
RESULTS
In 8 groups of rat hearts perfused under the conditions listed in Table 1 and without inhibitors (groups 1-8), the malonyl-CoA concentrations ranged from 1.5 nmol@g !1 (hearts from fed rats perfused with 1 µM epinephrine) to 5 nmol@g !1 (hearts from two-day starved rats perfused with 0.8 mM octanoate). Groups 1-8 are listed in Table 1 The effect of two inhibitors of MCD, CBM-300864 and CBM-301940 was tested in hearts perfused with buffer containing 1% DMSO. In the control group (group 6), 1% DMSO did not affect the relationship between concentration and turnover of malonyl-CoA (Fig 2) . The two inhibitors increased the concentration of malonyl-CoA (Table 2) , and 30 µM CBM-300864 significantly decreased the turnover of malonyl-CoA (Fig 1B, Fig 2, open symbols) .
We measured the malonyl-CoA concentration and turnover in the hearts of 6 anesthetized pigs to get data from an animal species whose metabolic rate per kg is close to that of adult humans.
The malonyl-CoA concentration was 1.3 ± 0.3 nmol/g wet wt, and its turnover was 0.15 nmol·min -1 ·g wet wt -1 . Thus, in live pig hearts the malonyl-CoA concentration is comparable to that of the perfused rat heart, but the rate of turnover is about 70-80% lower.
DISCUSSION
This study was conducted to gain insight on the dynamics of the malonyl-CoA pool which plays a major role in controlling fatty acid oxidation in the heart. To date, the regulation of malonylCoA metabolism in the heart has been studied (i) by defining the factors that modulate the activities of ACC and MCD, and (ii) by correlating malonyl-CoA concentrations with activities of carnitine-palmitoyltransferase I and with rates of fatty acid oxidation. Our study was aimed at In the heart, the only known fate of malonyl-CoA is its decarboxylation to acetyl-CoA by MCD.
Therefore when the malonyl-CoA concentration is stable (as was the case in our experiments), inhibition with CBM-300863 and CBM-301940 increases malonyl-CoA concentration (17) . In the present study we demonstrated that the rise in malonyl-CoA with MCD inhibition was due to a decrease in malonyl-CoA turnover (Figs 1 and 2 , compare groups 9-11 to group 6, the DMSO control). The data of groups 9-11 no longer followed the relationship between malonyl-CoA concentration and turnover of groups 1-8. The two inhibitors did not affect the activity of ACC assayed in rat heart extract (not shown). It appears that the inhibitors indirectly inhibited acetylCoA carboxylation by increasing product inhibition on ACC, presumably without affecting the cytosolic acetyl-CoA concentration.
In conclusion, our data demonstrate that, in the absence of inhibitors, the rate of acetyl-CoA carboxylation varies with the mix of substrates offered to the heart, but appears to be independent of the ACC and MCD activities measured under Vmax conditions. There is evidence that most of the tissue content of acetyl-CoA is mitochondrial. Therefore, the cytosolic concentration of acetyl-CoA must be in the low µM range. Since the Km of ACC for acetylCoA is much higher than the cytosolic concentration of acetyl-CoA, the latter must be a key short-term modulator of the ACC flux, as previously hypothesized (8;10;18) . Future studies will investigate the respective roles of the various sources of cytosolic acetyl-CoA, which include not only mitochondria, but also peroxisomes (19).
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Table 1. Perfusion conditions and malonyl-CoA content of isolated rat hearts
In all groups, the non-recirculating perfusate contained 50 µM carnitine and 3 nM insulin, as well as 3% bovine serum albumin (BSA, except where indicated). The status of the rats refers to them being fed, overnight-fasted (ONF), or two-day starved (2DS). The first 8 groups of perfusions are listed in the order of increasing malonyl-CoA concentrations measured in the tissue. Group 6 (1% DMSO) is the control for groups 9, 10, 11 (inhibitors of MCD) (n = 7 for each group) (*p<0.01 compared to group 6). Table 2 Activities of ACC and MCD in perfused rat hearts
Concentrations of compounds
The activities, expressed in nmolCmin -1 C(g wet weight) -1 , were assayed in six of the groups of perfused rat hearts described in Table 1 . The data are mean ± SE (n = 7 for each group). perfused rat hearts. Each numbered symbol refers to one group of perfused hearts described in Table 1 .
ACC activity
The linear regression was computed from the data of groups 1 to 8. 
